COVID-19, caused by SARS-Cov-2, was declared to be a pandemic by the World Health Organization on 11 March 2020. Since … then, the issue of the relationship between patent protection and the development of and access to medical treatments and … an overview of the patent landscape of medical treatments and technologies related to COVID-19, and of the patent status …

the proliferation of immunity-escaping variants. Therefore governmental rationality around the world would suggest any … governments should bear the cost of the expected increased industry obsolescence determined by a temporary patent waiver; this … includes public patent-buy-outs and regulated public-private R&D partnerships. …

The World Trade Organisation’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS … resolve the access problems. The comment concludes that the key patent problem is the transfer of know-how and that developing … new ideas about addressing these patent know-how transfers is the presently unaddressed challenge …

support national patent offices and interested parties in developing countries with information that can serve as guidance for … the examination of the claims contained in relevant patents or patent applications. The medicines considered for the … patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the …